ISTH DIC subcommittee communication on anticoagulation in COVID‐19

Hypercoagulability is an increasingly recognized complication of SARS‐CoV‐2 infection. As such, anticoagulation has become part and parcel of comprehensive COVID‐19 management. However, several uncertainties exist in this area, including the appropriate type and dose of heparin. In addition, special...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Thromb Haemost
Egile Nagusiak: Thachil, Jecko, Juffermans, Nicole P., Ranucci, Marco, Connors, Jean M., Warkentin, Theodore E., Ortel, Thomas L., Levi, Marcel, Iba, Toshiaki, Levy, Jerrold H.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. 2020
Gaiak:
Recommendations and Guidelines
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7404846/
https://ncbi.nlm.nih.gov/pubmed/32881336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.15004
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak